Bukwang Pharmaceutical said it has donated medical supplies to Daeyang Luke Hospital in Malawi, Africa, through Everservant, a local non-profit organization .
The donation includes 100,000 tablets of Tazenol 8-Hour Extended-Release and 50,000 tablets of Tazenol 500 mg, totaling 150,000 tablets. Tazenol’s active ingredient, acetaminophen, is effective in relieving fever and pain caused by colds, as well as headaches, neuralgia, and muscle pain.
Daeyang Luke Hospital is a 180-bed general hospital established by a Korean in 2008, with the goal to improve Malawi’s underdeveloped healthcare environment and provide medical care to impoverished and vulnerable patients.
Everservant supports healthcare and poverty alleviation efforts in Africa. The organization also works to foster mutual understanding and friendship between Korea and African nations through various initiatives.
“We are honored that Tazenol, one of Bukwang’s flagship products, can contribute to improving healthcare in Africa,” Bukwang CEO Lee Je-young said. “We will continue to support regions in need of medical supplies both locally and internationally, and we are committed to ongoing social contribution efforts.”
Related articles
- Bukuang Pharma launches Latuda to treat schizophrenia and bipolar disorder-related depression
- 24 drugmakers extend their state-designated "innovative pharma" title until 2027
- Bukwang Pharma halts JM-010 clinical trials after setback
- Contera Pharma announces unsuccessful P2b study for dyskinesia treatment candidate
